SCHEMBL81693

SCHEMBL81693

CCCCCCCCCCCCCCCC[N+](C)(C)CC(O)CS(=O)(=O)O

nearest known ligand 0.53

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PLA2G1B P04054 3/20 0.53
ATG4B Q9Y4P1 3/20 0.53
HSP90AA1 P07900 3/20 0.53
PSMD14 O00487 2/20 0.53
MMP2 P08253 2/20 0.53
HTT P42858 3/20 0.45
DNM1 Q05193 10/20 0.44
KMT2A Q03164 1/20 0.42
RAD52 P43351 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10937597 1.00 PLA2G1B (0.53) PLA2G1BATG4BHSP90AA1PSMD14MMP2
SCHEMBL11770996 1.00 PLA2G1B (0.53) PLA2G1BATG4BHSP90AA1PSMD14MMP2
SCHEMBL1104430 1.00 PLA2G1B (0.53) PLA2G1BATG4BHSP90AA1PSMD14MMP2
SCHEMBL10933452 1.00 PLA2G1B (0.53) PLA2G1BATG4BHSP90AA1PSMD14MMP2
SCHEMBL6237613 1.00 PLA2G1B (0.53) PLA2G1BATG4BHSP90AA1PSMD14MMP2
SCHEMBL6242053 1.00 PLA2G1B (0.53) PLA2G1BATG4BHSP90AA1PSMD14MMP2
SCHEMBL10934245 1.00 PLA2G1B (0.53) PLA2G1BATG4BHSP90AA1PSMD14MMP2
SCHEMBL10934552 1.00 PLA2G1B (0.53) PLA2G1BATG4BHSP90AA1PSMD14MMP2
SCHEMBL10937702 1.00 PLA2G1B (0.53) PLA2G1BATG4BHSP90AA1PSMD14MMP2
SCHEMBL10935342 1.00 PLA2G1B (0.53) PLA2G1BATG4BHSP90AA1PSMD14MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1752 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8268765-B2 Mono-, di- and polyol phosphate esters in personal care formulations RHODIA OPERATIONS (FR) 2012-09-18 US claimed
US-7666824-B2 skin wash products that include a skin benefit ingredient, such as a barrier enhancing agent, that can be easily transferred to the skin from the wash product; liquid phase containing sterols and natural fat or oil; microencapsulated KIMBERLY-CLARK WORLDWIDE, INC. (US) 2010-02-23 US claimed
US-7268104-B2 Color changing liquid cleansing products KIMBERLY-CLARK WORLDWIDE, INC. (US) 2007-09-11 US claimed
EP-1678289-B1 BAR SOAP COMPOSITION WITH REDUCED BAR WEAR PROPERTIES COLGATE PALMOLIVE CO (US) 2007-04-11 EP claimed
EP-1678289-A1 BAR SOAP COMPOSITION WITH REDUCED BAR WEAR PROPERTIES Colgate-Palmolive Company (US) 2006-07-12 EP claimed
US-7045491-B2 Bar soap composition with reduced bar wear properties COLGATE-PALMOLIVE COMPANY (US) 2006-05-16 US claimed
WO-2005107691-A1 LAMELLAR STRUCTURED LIQUID CLEANSER COMPOSITIONS KIMBERLY-CLARK WORLDWIDE, INC. (US) 2005-11-17 WO claimed
US-20050239669-A1 skin wash products that include a skin benefit ingredient, such as a barrier enhancing agent, that can be easily transferred to the skin from the wash product; liquid phase containing sterols and natural fat or oil; microencapsulated KIMBERLY-CLARK WORLDWIDE, INC. 2005-10-27 US claimed
WO-2005067875-A1 COLOR CHANGING LIQUID CLEANSING PRODUCTS KIMBERLY-CLARK WORLDWIDE, INC. (US) 2005-07-28 WO claimed
US-20050148490-A1 Color changing liquid cleansing products KIMBERLY-CLARK WORLDWIDE, INC. 2005-07-07 US claimed
EP-0756633-B1 METHOD AND KITS FOR PROCESSING MYCOBACTERIA AND MYCOLIC ACID CONTAINING BACTERIA INTEGRATED RES TECHNOLOGY LLC (US) 2005-06-08 EP claimed
US-20050107273-A1 Bar soap composition with reduced bar wear properties COLGATE-PALMOTIVE COMPANY 2005-05-19 US claimed
WO-2005044970-A1 BAR SOAP COMPOSITION WITH REDUCED BAR WEAR PROPERTIES COLGATE-PALMOLIVE COMPANY (US) 2005-05-19 WO claimed
US-6838420-B2 A translucent or transparent composition comprising about 3 to about 40 wt. % soap, about 4 to about 40 wt. % of at least one synthetic surfactant, and water, lower monohydric alcohol, a humectant, a structurant, and gellant are not 0 at the COLGATE-PALMOLIVE COMPANY (US) 2005-01-04 US claimed
EP-0915693-B1 AN OIL-IN-WATER EMULSION FOR USE ON HUMAN SKIN FOR CLEANSING, PRESERVING OR IMPROVING THE CONDITION OF THE SKIN PLUM KEMI PRODUKTION AS (DK) 2003-10-01 EP claimed
EP-0915693-A1 AN OIL-IN-WATER EMULSION FOR USE ON HUMAN SKIN FOR CLEANSING, PRESERVING OR IMPROVING THE CONDITION OF THE SKIN Plum Kemi Produktion A/S (DK) 1999-05-19 EP claimed
WO-1998005294-A1 AN OIL-IN-WATER EMULSION FOR USE ON HUMAN SKIN FOR CLEANSING, PRESERVING OR IMPROVING THE CONDITION OF THE SKIN PLUM KEMI PRODUKTION A/S (DK) 1998-02-12 WO claimed
US-4005029-A Laundering adjunct THE PROCTER & GAMBLE COMPANY (US) 1977-01-25 US claimed
EP-4227391-B1 DETERGENT COMPOSITION THAT PERFORMS BOTH A CLEANING AND RINSING FUNCTION ECOLAB USA INC (US) 2026-05-27 EP disclosed
US-3934002-A BIS-GUANIDE THE PROCTER & GAMBLE COMPANY (US) 1976-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107273-A1 Bar soap composition with reduced bar wear properties DDHD2, SORD, CRABP2 PLA2G1B 702/4885ATG4B 2158/4885HSP90AA1 1079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.